banner

News Details

Home > News >

Company news about KORNNAC Pharma Presents Liquid-Filled Capsules & CDMO at Vitafoods Asia 2026

Events
Contact Us
Mr. Zhang
86-15271868127
Contact Now

KORNNAC Pharma Presents Liquid-Filled Capsules & CDMO at Vitafoods Asia 2026

2026-09-02

BANGKOK, Thailand — September 2, 2026KORNNAC Pharma, a premier global contract development and manufacturing organization (CDMO) specializing in advanced nutraceutical delivery systems, officially kicked off its participation at Vitafoods Asia 2026 today. Located at Booth H2-H25 in the Queen Sirikit National Convention Center (QSNCC), the KORNNAC Pharma team is engaging with global healthcare brands, distributors, and formulators seeking next-generation supplement solutions.

With the Asian nutraceutical market rapidly shifting toward high-efficacy, visually distinct, and scientifically backed dosage forms, KORNNAC Pharma is highlighting its full portfolio of advanced liquid technologies and integrated manufacturing capabilities.

Pioneering Delivery Systems: Liquid-Filled & Beadlet-in-Oil Technologies

At this year's exhibition, KORNNAC Pharma is showcasing its market-leading liquid encapsulation and multi-phase delivery capabilities designed to resolve complex active ingredient stability challenges.

Visitors to Booth H2-H25 can examine live product samples showcasing:

  • Beadlet-in-Oil Capsules: Combining lipophilic oils with targeted-release solid beadlets within a single capsule. This technology enables dual-release profiles, prevents active ingredient cross-interaction, and offers striking aesthetic appeal for premium brand positioning.

  • Liquid Hard Capsules (HPMC, Pullulan, and Gelatin): Utilizing advanced hermetic sealing technology to prevent leakage and oxidation, ensuring optimal potency for volatile or moisture-sensitive nutrients such as Omega-3s, botanical extracts, vitamins, and lipophilic actives.

latest company news about KORNNAC Pharma Presents Liquid-Filled Capsules & CDMO at Vitafoods Asia 2026  0
End-to-End CDMO Workflow: From Concept to Scale-Up Commercialization

As global brand owners navigate evolving market demands, KORNNAC Pharma provides a comprehensive, one-stop CDMO partner model that minimizes time-to-market and lowers supply chain risk.

The KORNNAC Pharma technical team on-site in Bangkok is providing interactive consultations covering the entire product lifecycle:

  1. Custom Formulation Development: Tailoring ingredient combinations, bioavailability enhancements, and dosage specs.

  2. Pilot Trials & Lab Batch Scaling: Ensuring robust analytical testing, dissolution optimization, and formulation stability.

  3. Full Scale-Up Manufacturing: Delivering reliable, high-volume output across multiple hard capsule shell materials (including HPMC, Pullulan, and Gelatin).

Stringent Quality Assurance & Global Regulatory Compliance

To support international brand expansion, all manufacturing processes under KORNNAC Pharma strictly comply with internationally recognized Good Manufacturing Practices (GMP). By adhering to rigorous regulatory frameworks, KORNNAC Pharma helps global clients seamlessly obtain regional market approvals across Southeast Asia, Europe, and North America.

banner
News Details
Home > News >

Company news about-KORNNAC Pharma Presents Liquid-Filled Capsules & CDMO at Vitafoods Asia 2026

KORNNAC Pharma Presents Liquid-Filled Capsules & CDMO at Vitafoods Asia 2026

2026-09-02

BANGKOK, Thailand — September 2, 2026KORNNAC Pharma, a premier global contract development and manufacturing organization (CDMO) specializing in advanced nutraceutical delivery systems, officially kicked off its participation at Vitafoods Asia 2026 today. Located at Booth H2-H25 in the Queen Sirikit National Convention Center (QSNCC), the KORNNAC Pharma team is engaging with global healthcare brands, distributors, and formulators seeking next-generation supplement solutions.

With the Asian nutraceutical market rapidly shifting toward high-efficacy, visually distinct, and scientifically backed dosage forms, KORNNAC Pharma is highlighting its full portfolio of advanced liquid technologies and integrated manufacturing capabilities.

Pioneering Delivery Systems: Liquid-Filled & Beadlet-in-Oil Technologies

At this year's exhibition, KORNNAC Pharma is showcasing its market-leading liquid encapsulation and multi-phase delivery capabilities designed to resolve complex active ingredient stability challenges.

Visitors to Booth H2-H25 can examine live product samples showcasing:

  • Beadlet-in-Oil Capsules: Combining lipophilic oils with targeted-release solid beadlets within a single capsule. This technology enables dual-release profiles, prevents active ingredient cross-interaction, and offers striking aesthetic appeal for premium brand positioning.

  • Liquid Hard Capsules (HPMC, Pullulan, and Gelatin): Utilizing advanced hermetic sealing technology to prevent leakage and oxidation, ensuring optimal potency for volatile or moisture-sensitive nutrients such as Omega-3s, botanical extracts, vitamins, and lipophilic actives.

latest company news about KORNNAC Pharma Presents Liquid-Filled Capsules & CDMO at Vitafoods Asia 2026  0
End-to-End CDMO Workflow: From Concept to Scale-Up Commercialization

As global brand owners navigate evolving market demands, KORNNAC Pharma provides a comprehensive, one-stop CDMO partner model that minimizes time-to-market and lowers supply chain risk.

The KORNNAC Pharma technical team on-site in Bangkok is providing interactive consultations covering the entire product lifecycle:

  1. Custom Formulation Development: Tailoring ingredient combinations, bioavailability enhancements, and dosage specs.

  2. Pilot Trials & Lab Batch Scaling: Ensuring robust analytical testing, dissolution optimization, and formulation stability.

  3. Full Scale-Up Manufacturing: Delivering reliable, high-volume output across multiple hard capsule shell materials (including HPMC, Pullulan, and Gelatin).

Stringent Quality Assurance & Global Regulatory Compliance

To support international brand expansion, all manufacturing processes under KORNNAC Pharma strictly comply with internationally recognized Good Manufacturing Practices (GMP). By adhering to rigorous regulatory frameworks, KORNNAC Pharma helps global clients seamlessly obtain regional market approvals across Southeast Asia, Europe, and North America.